Please use this identifier to cite or link to this item:
https://doi.org/10.1074/jbc.M503016200
DC Field | Value | |
---|---|---|
dc.title | Identification of TopBP1 as a c-Abl-interacting protein and a repressor for c-Abl expression | |
dc.contributor.author | Zeng, L. | |
dc.contributor.author | Hu, Y. | |
dc.contributor.author | Li, B. | |
dc.date.accessioned | 2016-12-13T05:36:34Z | |
dc.date.available | 2016-12-13T05:36:34Z | |
dc.date.issued | 2005-08-12 | |
dc.identifier.citation | Zeng, L., Hu, Y., Li, B. (2005-08-12). Identification of TopBP1 as a c-Abl-interacting protein and a repressor for c-Abl expression. Journal of Biological Chemistry 280 (32) : 29374-29380. ScholarBank@NUS Repository. https://doi.org/10.1074/jbc.M503016200 | |
dc.identifier.issn | 00219258 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/132790 | |
dc.description.abstract | Expression of BCR-ABL is the leading cause of chronic myelogenous leukemia. In chronic myelogenous leukemia cells, c-Abl expression is silenced by promoter methylation. In addition, the level of c-Abl needs to be tightly and constantly regulated due to its cytotoxicity and its rapid degradation after activation. Yet the regulation of c-Abl expression remains unclear. In an effort to gain better understanding of c-Abl function, we performed a glutathione S-transferase-Abl pull-down screen and identified TopBP1, a topoisomerase IIβ-binding protein that contains Brca1 C-terminal motifs and has been implicated in DNA damage response. Their physical interaction was verified by in vitro and in vivo assays with TopBP1 found as a substrate of Abl proteins. TopBP1 could repress the expression of c-Abl at both mRNA and protein levels. Reporter assays indicate that TopBP1 directly repressed the promoter activity of c-Abl. Furthermore, TopBP1 repressed expression of c-Abl through a novel mechanism that involved histone deacetylation and DNA methylation. This transcriptional repression was inhibited by c-Abl in a kinase-dependent manner. The dual antagonistic interplay between c-Abl and TopBP1 may also provide a mechanism for fine-tuning of c-Abl levels. © 2005 by The American Society for Biochemistry and Molecular Biology, Inc. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1074/jbc.M503016200 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | MEDICINE | |
dc.description.doi | 10.1074/jbc.M503016200 | |
dc.description.sourcetitle | Journal of Biological Chemistry | |
dc.description.volume | 280 | |
dc.description.issue | 32 | |
dc.description.page | 29374-29380 | |
dc.description.coden | JBCHA | |
dc.identifier.isiut | 000231021300069 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.